VIDEO: BioTissue launches CAM360 AmnioGraft for dry eye, ocular surface disease
Click Here to Manage Email Alerts
KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Roger Kennedy, director of marketing for BioTissue, announces the launch of the CAM360 AmnioGraft.
CAM 360 AG is a ringless cryopreserved amniotic membrane that adheres under a bandage contact lens to treat mild to moderate dry eye and ocular surface disease.
“BioTissue is going to be launching the first and only cryopreserved amniotic membrane designed to optimize comfort,” Kennedy said. “It really allows BioTissue to be able to help offer our customers in the eye care community and patients relief and options for when they’re suffering any type of dry eye disease or any type of ocular surface disease in general.”
Reference:
- BioTissue introduces CAM360 AmnioGraft, redefining regenerative therapy for dry eye and other ocular surface disorders. https://biotissue.com/news/biotissue-introduces-cam360-amniograft-redefining-regenerative-therapy-for-dry-eye-and-other-ocular-surface-disorders/. Published June 3, 2024. Accessed June 3, 2024.
Collapse
Healio Interviews
Click Here to Manage Email Alerts